Richard M. Welch

3.7k total citations
80 papers, 3.0k citations indexed

About

Richard M. Welch is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Richard M. Welch has authored 80 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Pharmacology and 12 papers in Pharmacology. Recurrent topics in Richard M. Welch's work include Effects and risks of endocrine disrupting chemicals (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Estrogen and related hormone effects (8 papers). Richard M. Welch is often cited by papers focused on Effects and risks of endocrine disrupting chemicals (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Estrogen and related hormone effects (8 papers). Richard M. Welch collaborates with scholars based in United States, United Kingdom and Netherlands. Richard M. Welch's co-authors include Allan H. Conney, Wayne Levin, John W. A. Findlay, A. H. Conney, R. Kuntzman, Robert F. Butz, Richard DeAngelis, Mieczyslaw Finster, P. J. Poppers and J.J. Burns and has published in prestigious journals such as Science, Circulation and Trends in Biochemical Sciences.

In The Last Decade

Richard M. Welch

80 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard M. Welch United States 34 836 545 523 376 368 80 3.0k
F. Berthou France 39 1.9k 2.2× 288 0.5× 1.2k 2.2× 471 1.3× 339 0.9× 119 4.3k
Ulf Bondesson Sweden 33 685 0.8× 330 0.6× 674 1.3× 503 1.3× 416 1.1× 156 3.8k
D. S. Davies United Kingdom 32 711 0.9× 274 0.5× 801 1.5× 246 0.7× 199 0.5× 93 3.2k
Yvonne Dréano France 30 1.1k 1.4× 150 0.3× 613 1.2× 313 0.8× 276 0.8× 59 2.7k
A. Schmoldt Germany 23 487 0.6× 336 0.6× 555 1.1× 441 1.2× 140 0.4× 112 2.9k
Robert E. McMahon United States 33 704 0.8× 221 0.4× 856 1.6× 386 1.0× 112 0.3× 131 3.1k
Jerry B. Hook United States 36 1.3k 1.5× 509 0.9× 974 1.9× 436 1.2× 631 1.7× 216 4.2k
Stephen P. Spielberg United States 36 793 0.9× 280 0.5× 700 1.3× 913 2.4× 845 2.3× 90 3.7k
Nobumitsu Hanioka Japan 29 1.3k 1.6× 687 1.3× 953 1.8× 235 0.6× 333 0.9× 144 3.3k
Olavi Pelkonen Finland 29 1.3k 1.6× 334 0.6× 673 1.3× 294 0.8× 323 0.9× 68 2.7k

Countries citing papers authored by Richard M. Welch

Since Specialization
Citations

This map shows the geographic impact of Richard M. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Welch more than expected).

Fields of papers citing papers by Richard M. Welch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard M. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Welch. The network helps show where Richard M. Welch may publish in the future.

Co-authorship network of co-authors of Richard M. Welch

This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Welch. A scholar is included among the top collaborators of Richard M. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Welch. Richard M. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ardlie, Kristin G., et al.. (2006). Genetic Variations in CC Chemokine Receptors and Hypertension. American Journal of Hypertension. 19(1). 67–72. 8 indexed citations
2.
Clifton, G. Dennis, Michael R. Harrison, Daniel P. Wermeling, et al.. (1994). Pharmacokinetics and pharmacodynamics of a new cardiotonic vasodilator agent, 349U85, in normal subjects. Clinical Pharmacology & Therapeutics. 55(1). 55–63. 1 indexed citations
3.
Cook, D. Ryan, Richard L. Stiller, J. N. Weakly, et al.. (1989). In Vitro Metabolism of Mivacurium Chloride (BW B1090U) and Succinylcholine. Anesthesia & Analgesia. 68(4). 452???456–452???456. 93 indexed citations
4.
Warren, James T., et al.. (1982). Plasma Levels of a Novel Antidysrhythmic Agent, Meobentine Sulfate, in Humans as Determined by Radioimmunoassay. Journal of Pharmaceutical Sciences. 71(6). 665–670. 6 indexed citations
5.
Butz, Robert F., Richard M. Welch, & John W. A. Findlay. (1982). Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 676–685. 18 indexed citations
6.
Schroeder, David H., et al.. (1980). Metabolism and disposition of carbon 14 labeled bupropion in rats. 22(3). 188. 3 indexed citations
7.
Welch, Richard M. & W. A. House. (1980). Absorption of radiocadmium and radioselenium by rats fed intrinsically and extrinsically labeled lettuce leaves.. Nutrition reports international. 21(1). 135–145. 25 indexed citations
8.
Findlay, John W. A., Robert F. Butz, & Richard M. Welch. (1977). Specific radioimmunoassays for codeine and morphine. Metabolism of codeine to morphine in the rat.. PubMed. 17(4). 595–603. 8 indexed citations
9.
Cantekin, Erdem I., et al.. (1977). Nasal Decongestant Activity of Pseudoephedrine. Annals of Otology Rhinology & Laryngology. 86(2). 235–242. 52 indexed citations
10.
DeAngelis, Richard, Mary F. Kearney, & Richard M. Welch. (1977). Determination of Triprolidine in Human Plasma by Quantitative TLC. Journal of Pharmaceutical Sciences. 66(6). 841–843. 13 indexed citations
11.
Levin, Wayne, Richard M. Welch, & A. H. Conney. (1974). INCREASED LIVER MICROSOMAL ANDROGEN METABOLISM BY PHENOBARBITAL: CORRELATION WITH DECREASED ANDROGEN ACTION ON THE SEMINAL VESICLES OF THE RAT. Journal of Pharmacology and Experimental Therapeutics. 188(2). 287–292. 21 indexed citations
12.
Conney, Allan H., Richard M. Welch, R. Kuntzman, et al.. (1971). EFFECTS OF ENVIRONMENTAL CHEMICALS ON THE METABOLISM OF DRUGS, CARCINOGENS, AND NORMAL BODY CONSTITUENTS IN MAN. Annals of the New York Academy of Sciences. 179(1). 155–172. 63 indexed citations
13.
Levin, Wayne, Richard M. Welch, & A. H. Conney. (1970). EFFECT OF CARBON TETRACHLORIDE AND OTHER INHIBITORS OF DRUG METABOLISM ON THE METABOLISM AND ACTION OF ESTRADIOL-17β AND ESTRONE IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 173(2). 247–255. 3 indexed citations
14.
15.
Welch, Richard M., Wayne Levin, & Allan H. Conney. (1969). Estrogenic action of DDT and its analogs. Toxicology and Applied Pharmacology. 14(2). 358–367. 264 indexed citations
16.
Levin, Wayne, Richard M. Welch, & Allan H. Conney. (1968). Decreased Uterotropic Potency of Oral Contraceptives in Rats Pretreated with Phenobarbital1. Endocrinology. 83(1). 149–156. 38 indexed citations
17.
Levin, Wayne, Richard M. Welch, & Allan H. Conney. (1967). Effect of Chronic Phenobarbital Treatment on the Liver Microsomal Metabolism and Uterotropic Action of 17β-Estradiol1. Endocrinology. 80(1). 135–140. 46 indexed citations
18.
Kuntzman, R., Richard M. Welch, & Allan H. Conney. (1966). Factors influencing steroid hydroxylases in liver microsomes. Advances in Enzyme Regulation. 4. 149–160. 59 indexed citations
19.
Welch, Richard M. & Allan H. Conney. (1965). A Simple Method for the Quantitative Determination of N-Acetyl-p-Aminophenol (APAP) in Urine. Clinical Chemistry. 11(12). 1064–1067. 50 indexed citations
20.
Welch, Richard M. & Julius M. Coon. (1964). STUDIES ON THE EFFECT OF CHLORCYCLIZINE AND OTHER DRUGS ON THE TOXICITY OF SEVERAL ORGANOPHOSPHATE ANTICHOLINESTERASES. Journal of Pharmacology and Experimental Therapeutics. 143(2). 192–198. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Berthou Breakdown of academic impact, for papers by Ulf Bondesson Breakdown of academic impact, for papers by D. S. Davies Breakdown of academic impact, for papers by Yvonne Dréano Breakdown of academic impact, for papers by A. Schmoldt Breakdown of academic impact, for papers by Robert E. McMahon Breakdown of academic impact, for papers by Jerry B. Hook Breakdown of academic impact, for papers by Stephen P. Spielberg Breakdown of academic impact, for papers by Nobumitsu Hanioka Breakdown of academic impact, for papers by Olavi Pelkonen
Rankless by CCL
2026